Incretin-based Drugs and the Risk of Heart Failure

NCT02456428 · clinicaltrials.gov ↗

COMPLETED

Status

1499650

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: DPP-4 inhibitors
DRUG: GLP-1 analogs
DRUG: Insulins
DRUG: Biguanides
DRUG: Sulfonylureas
DRUG: Thiazolidinediones
DRUG: Alpha-glucosidase inhibitors
DRUG: Meglitinides

Sponsor

Canadian Network for Observational Drug Effect Studies, CNODES

Collaborators

[object Object]
[object Object]